Credit Agricole S A Sangamo Therapeutics, Inc Transaction History

Credit Agricole S A

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$5.05 - $8.85 $10,100 - $17,700	-2,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $700,000 - $1.04 Million	-80,000 Reduced 97.56%	2,000 $22,000
Q1 2019 May 14, 2019	BUY	$7.72 - $12.81 $617,600 - $1.02 Million	80,000 Added 4000.0%	82,000 $783,000
Q2 2018 Aug 10, 2018	BUY	$13.9 - $19.8 $27,800 - $39,600	2,000 New	2,000 $28,000

124

62.2M

953K

1.11M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $68.9M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.